Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
Pils D, Hager G, Tong D, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Cadron I, Mahner S, Hofstetter G, Speiser P, Zeillinger R.
Pils D, et al. Among authors: aust s.
Cancer Sci. 2012 Jul;103(7):1334-41. doi: 10.1111/j.1349-7006.2012.02306.x. Epub 2012 May 17.
Cancer Sci. 2012.
PMID: 22497737
Free PMC article.